abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

ADAM9
Back
Total number of drugs
15
Phase II and later clinical stages
0%
Involving companies
14
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
BG-C0979BG-C0979Antibody drug conjugate (ADC) ADCNeoplasmsADAM metallopeptidase domain 9 inhibitors DNA topoisomerase I inhibitorsBeOne Medicines Ltd.BeOne Medicines Ltd.Phase 1Phase 1BG-C0979
detail  >
DB-1317DB-1317Antibody drug conjugate (ADC) ADCNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease Respiratory Diseases Urogenital DiseasesADAM metallopeptidase domain 9 inhibitorsDuality Biologics (Suzhou) Co., Ltd.DualityBio Inc.Phase 1Phase 1DB-1317
detail  >
MGC-028MGC-028Antibody drug conjugate (ADC) ADCNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease Respiratory Diseases Other DiseasesADAM metallopeptidase domain 9 inhibitors DNA topoisomerase I inhibitorsMacroGenics, Inc.MacroGenics, Inc.Phase 1Val-AlaExatecan 依喜替康4MGC-028asparagine 天冬酰胺
detail  >
IzeltabartIzeltabartMonoclonal antibodyADAM metallopeptidase domain 9 inhibitorsClinicalIzeltabart
detail  >
Izeltabart TapatansineIzeltabart TapatansineAntibody drug conjugate (ADC) ADCADAM metallopeptidase domain 9 inhibitors Tubulin inhibitorsClinicalMal-Ala-AlaMaytansinoid DM21 DM21Izeltabart TapatansineIgG1 - kappa
detail  >
ADAM9 ADC(Henlius)ADAM9 ADC(Henlius)Antibody drug conjugate (ADC) ADCNeoplasmsADAM metallopeptidase domain 9 inhibitorsShanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.PreclinicalPreclinicalADAM9 ADC(Henlius)
detail  >
ADAM9 ADC(Hongcheng)ADAM9 ADC(Hongcheng)Antibody drug conjugate (ADC) ADCADAM metallopeptidase domain 9 inhibitorsJiangsu Hongcheng Biotechnology Co., Ltd.Shanghai Huaaotai Biopharmaceutical Co., Ltd.PreclinicalPreclinicalADAM9 ADC(Hongcheng)
detail  >
Anti-Adam9 Antibody Drug Conjugate(Immunogen)Anti-Adam9 Antibody Drug Conjugate(Immunogen)Antibody drug conjugate (ADC) ADCNeoplasmsADAM metallopeptidase domain 9 inhibitors Tubulin inhibitorsImmunoGen, Inc.ImmunoGen, Inc.PreclinicalSPDBMaytansinoid DM4 美登素DM4Anti-Adam9 Antibody Drug Conjugate(Immunogen)lysyl 赖氨酸
detail  >
Anti-ADAM9 Antibody(Mabwell bioscience)Anti-ADAM9 Antibody(Mabwell bioscience)AntibodyNeoplasmsADAM metallopeptidase domain 9 inhibitorsMabwell (Shanghai) Bioscience Co., Ltd.Mabwell (Shanghai) Bioscience Co., Ltd.PreclinicalPreclinicalAnti-ADAM9 Antibody(Mabwell bioscience)
detail  >
XYD-8006XYD-8006Dual payload Antibody drug conjugate (Dual payload ADC)Neoplasms Digestive System Disorders Respiratory DiseasesADAM metallopeptidase domain 9 inhibitors Tubulin inhibitorsKunshan Xinyunda Biotechnology Co., Ltd.FDC PharmaKunshan Xinyunda Biotechnology Co., Ltd.PreclinicalPreclinicalMMAE 甲基澳瑞他汀EXYD-8006
detail  >
Total 15 data
1
2